{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:05:20Z","timestamp":1793851520060,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.rpth.2024.102345","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T17:57:25Z","timestamp":1710439045000},"page":"102345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Immune attack on megakaryocytes in immune thrombocytopenia"],"prefix":"10.1016","volume":"8","author":[{"given":"Eleonora","family":"Petito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gresele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102345_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.thromres.2006.09.008","article-title":"Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura","volume":"120","author":"Sakakura","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102345_bib3","article-title":"Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102345_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2004-03-0896","article-title":"Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI\/FcRgamma-chain complex from the human platelet surface","volume":"104","author":"Boylan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0037-1612660","article-title":"Anti-alphavbeta3 antibodies in chronic immune thrombocytopenic purpura","volume":"85","author":"Kosugi","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"Vrbensky","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.26036","article-title":"Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): impact of ITP on health-related quality of life","volume":"96","author":"Cooper","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102345_bib8","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","article-title":"The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review","volume":"83","author":"Abrahamson","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib12","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib13","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/bloodadvances.2017010942","article-title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry","volume":"1","author":"Arnold","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102345_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102345_bib15","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1182\/bloodadvances.2020004162","article-title":"Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102345_bib16","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/jth.14809","article-title":"Management of major bleeds in patients with immune thrombocytopenia","volume":"18","author":"Mithoowani","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib17","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102345_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/asheducation-2018.1.561","article-title":"How do we diagnose immune thrombocytopenia in 2018?","volume":"2018","author":"Kelton","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102345_bib19","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.rpth.2024.102345_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","article-title":"Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies","volume":"124","author":"Shulman","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rpth.2024.102345_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2141.1969.tb00379.x","article-title":"Sites of platelet destruction in idiopathic thrombocytopenic purpura","volume":"16","author":"Aster","year":"1969","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.1975.tb01839.x","article-title":"Platelet kinetics in idiopathic thrombocytopenic purpura (ITP) before and at different times after splenectomy","volume":"29","author":"Braneh\u00f6g","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1974.tb06780.x","article-title":"Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP)","volume":"27","author":"Braneh\u00f6g","year":"1974","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1182\/blood.V55.5.730.730","article-title":"Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia","volume":"55","author":"Kernoff","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2141.1997.832723.x","article-title":"The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies","volume":"97","author":"Najean","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1967.tb08755.x","article-title":"The platelet destruction site in thrombocytopenic purpuras","volume":"13","author":"Najean","year":"1967","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","article-title":"Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody","volume":"314","author":"Clarkson","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102345_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197405022901803","article-title":"Phagocytosis of antibody-coated platelets by human granulocytes","volume":"290","author":"Handin","year":"1974","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102345_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJM197401312900505","article-title":"In\u00a0vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura","volume":"290","author":"McMillan","year":"1974","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102345_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V50.6.1129.1129","article-title":"Platelet-bound complement (C3) in immune thrombocytopenia","volume":"50","author":"Hauch","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.1985.tb07477.x","article-title":"Platelet-associated complement in chronic ITP","volume":"60","author":"Kurata","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.1981.tb02786.x","article-title":"Fixation of C3 to platelets in\u00a0vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura","volume":"47","author":"McMillan","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2024.102345_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-0609.2005.00622.x","article-title":"Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura","volume":"76","author":"Zhang","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood.V45.4.551.551","article-title":"The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura(ITP)","volume":"45","author":"Braneh\u00f6g","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib36","first-page":"179","article-title":"The ultrastructure of the megakaryocytes in idiopathic thrombocytopenic purpura (ITP) in relation to thrombokinetics","volume":"11","author":"Ridell","year":"1976","journal-title":"Pathol Eur"},{"key":"10.1016\/j.rpth.2024.102345_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0002-9343(99)00054-6","article-title":"Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura","volume":"106","author":"Louwes","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2024.102345_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2141.2009.07717.x","article-title":"Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production","volume":"146","author":"Nugent","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V3.10.1090.1090","article-title":"A\u00a0study of the bone marrow from 36 patients with idiopathic hemorrhagic, thrombopenic purpura","volume":"3","author":"Diggs","year":"1948","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V8.8.703.703","article-title":"Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura","volume":"8","author":"Pisciotta","year":"1953","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.V67.2.421.421","article-title":"Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP","volume":"67","author":"Stahl","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ejh.12041","article-title":"A\u00a0blinded study of bone marrow examinations in patients with primary immune thrombocytopenia","volume":"90","author":"Mahabir","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib44","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1001\/jama.1978.03280500056020","article-title":"Antibody against megakaryocytes in idiopathic thrombocytopenic purpura","volume":"239","author":"McMillan","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102345_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/voxs.12155","article-title":"Megakaryopoiesis and ex\u00a0vivo differentiation of stem cells into megakaryocytes and platelets","volume":"10","author":"Pineault","year":"2015","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.rpth.2024.102345_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ejh.12528","article-title":"Antibody binding to megakaryocytes in\u00a0vivo in patients with immune thrombocytopenia","volume":"95","author":"Arnold","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib47","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2020001846","article-title":"Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia","volume":"4","author":"Shrestha","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102345_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"Lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2024.102345_bib49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ajh.20951","article-title":"The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab","volume":"82","author":"Kuwana","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102345_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.12105","article-title":"Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia","volume":"160","author":"Hara","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V84.2.625.625","article-title":"Antibodies to myeloid precursor cells in autoimmune neutropenia","volume":"84","author":"Hartman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib52","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/trf.13652","article-title":"Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes","volume":"56","author":"Zaninoni","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.rpth.2024.102345_bib53","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/ATVBAHA.119.312129","article-title":"New insights into the differentiation of megakaryocytes from hematopoietic progenitors","volume":"39","author":"Noetzli","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102345_bib54","first-page":"216","article-title":"Thrombopoietin: biology and clinical potentials","volume":"70","author":"Miyazaki","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2024.102345_bib55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: from megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.rpth.2024.102345_bib56","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2003-12-4398","article-title":"Differential regulation of actin stress fiber assembly and proplatelet formation by alpha2beta1 integrin and GPVI in human megakaryocytes","volume":"104","author":"Sabri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib57","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood-2005-11-011957","article-title":"Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3","volume":"108","author":"Larson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034449","article-title":"Outside-in signalling generated by a constitutively activated integrin \u03b1IIb\u03b23 impairs proplatelet formation in human megakaryocytes","volume":"7","author":"Bury","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102345_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125057","article-title":"Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism","volume":"10","author":"Avanzi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102345_bib60","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3324\/haematol.2018.204685","article-title":"Anti-apoptotic BCL2L2 increases megakaryocyte proplatelet formation in cultures of human cord blood","volume":"104","author":"Bhatlekar","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102345_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1083\/jcb.200210111","article-title":"Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death","volume":"160","author":"Clarke","year":"2003","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.rpth.2024.102345_bib62","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1182\/blood-2002-03-0686","article-title":"Platelet formation is the consequence of caspase activation within megakaryocytes","volume":"100","author":"De Botton","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib63","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/ATVBAHA.113.302184","article-title":"Crucial role for endoplasmic reticulum stress during megakaryocyte maturation","volume":"33","author":"Lopez","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102345_bib64","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1182\/blood-2011-12-398834","article-title":"Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival","volume":"119","author":"Debrincat","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib65","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.20110750","article-title":"Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets","volume":"208","author":"Josefsson","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rpth.2024.102345_bib66","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.V93.6.1951.406a33_1951_1958","article-title":"Influence of monoclonal antiplatelet glycoprotein antibodies on in\u00a0vitro human megakaryocyte colony formation and proplatelet formation","volume":"93","author":"Takahashi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib67","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in\u00a0vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib68","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in\u00a0vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib69","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood-2010-02-267435","article-title":"Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bjh.12832","article-title":"Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count","volume":"165","author":"Lev","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib71","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/jth.14214","article-title":"Autoantibody against integrin \u03b1v \u03b23 contributes to thrombocytopenia by blocking the migration and adhesion of megakaryocytes","volume":"16","author":"Zeng","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14977","article-title":"Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins","volume":"183","author":"Grodzielski","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib73","first-page":"3103","article-title":"Involvement of integrin alphavbeta3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma","volume":"56","author":"Yun","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.rpth.2024.102345_bib74","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/bloodadvances.2018026690","article-title":"Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia","volume":"3","author":"Wang","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102345_bib75","doi-asserted-by":"crossref","first-page":"a005074","DOI":"10.1101\/cshperspect.a005074","article-title":"Integrins in cell migration","volume":"3","author":"Huttenlocher","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.rpth.2024.102345_bib76","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3324\/haematol.2019.236117","article-title":"Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan","volume":"106","author":"Marini","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102345_bib77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2141.2007.06737.x","article-title":"CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura","volume":"139","author":"Li","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102345_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.2014.115634","article-title":"Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in\u00a0vitro","volume":"100","author":"Iraqi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102345_bib79","first-page":"2417","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib80","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2008-02-139402","article-title":"Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1","volume":"112","author":"Olsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102345_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.549842","article-title":"Natalizumab in multiple sclerosis treatment: from biological effects to immune monitoring","volume":"11","author":"Khoy","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2024.102345_bib82","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.168.12.6173","article-title":"Dual functions of fractalkine\/CX3C ligand 1 in trafficking of perforin+\/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression","volume":"168","author":"Nishimura","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rpth.2024.102345_bib83","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.7150\/ijbs.33779","article-title":"Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia","volume":"15","author":"Wang","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.rpth.2024.102345_bib84","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1160\/TH12-07-0468","article-title":"Differential expression of T-cell genes in blood and bone marrow between ITP patients and controls","volume":"109","author":"Jern\u00e5s","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rpth.2023.100563","article-title":"Anti-integrin immune thrombocytopenia autoantibodies impair megakaryocyte migration, polarization and proplatelet formation [abstract]","volume":"7","author":"Tondi","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102345_bib86","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2012.075648","article-title":"Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years","volume":"98","author":"Vianelli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102345_bib87","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58775","article-title":"Miniaturized 3D bone marrow tissue model to assess response to thrombopoietin-receptor agonists in patients","volume":"10","author":"Di Buduo","year":"2021","journal-title":"Elife"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:30:38Z","timestamp":1762864238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2475037924000347"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102345","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune attack on megakaryocytes in immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102345"}}